Covered recipient · General Payments record
KIMBERLEY A BOURNE-ARRIAGA
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$5,811.23
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,521.83 | 13 |
| Travel and Lodging | $602.05 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $1,082.61 | 7 |
| Medtronic, Inc. | $781.61 | 6 |
| Insulet Corporation | $95.01 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $86.63 | 1 |
| Corcept Therapeutics | $78.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $187.03 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125197497 | CMS |
| Abbott Laboratories | $157.00 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125197499 | CMS |
| Abbott Laboratories | $118.72 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125197501 | CMS |
| Abbott Laboratories | $157.43 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125197503 | CMS |
| Abbott Laboratories | $136.69 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125197509 | CMS |
| Abbott Laboratories | $151.72 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125197505 | CMS |
| Abbott Laboratories | $174.02 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125197507 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $86.63 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086136325 | CMS |
| Corcept Therapeutics | $78.02 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117729972 | CMS |
| Insulet Corporation | $95.01 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116815647 | CMS |
| Medtronic, Inc. | $350.00 | 09/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1112070410 | CMS |
| Medtronic, Inc. | $21.65 | 09/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1112070412 | CMS |
| Medtronic, Inc. | $90.90 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119434907 | CMS |
| Medtronic, Inc. | $44.33 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119434909 | CMS |
| Medtronic, Inc. | $44.33 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119434911 | CMS |
| Medtronic, Inc. | $230.40 | 10/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119434905 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.